Spots Global Cancer Trial Database for Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
Official Title: A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
Study ID: NCT00753688
Conditions
Study Description
Brief Summary: A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Birmingham, Alabama, United States
GSK Investigational Site, Los Angeles, California, United States
GSK Investigational Site, Orange, California, United States
GSK Investigational Site, Santa Monica, California, United States
GSK Investigational Site, Chicago, Illinois, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Minneapolis, Minnesota, United States
GSK Investigational Site, Clevand, Ohio, United States
GSK Investigational Site, Philadelphia, Pennsylvania, United States
GSK Investigational Site, Randwick, New South Wales, Australia
GSK Investigational Site, Woolloongabba, Queensland, Australia
GSK Investigational Site, Kurralta Park, South Australia, Australia
GSK Investigational Site, Hobart, Tasmania, Australia
GSK Investigational Site, Box Hill, Victoria, Australia
GSK Investigational Site, Nedlands, Western Australia, Australia
GSK Investigational Site, Brussels, , Belgium
GSK Investigational Site, Brussels, , Belgium
GSK Investigational Site, Gent, , Belgium
GSK Investigational Site, Leuven, , Belgium
GSK Investigational Site, Liège, , Belgium
GSK Investigational Site, Herlev, , Denmark
GSK Investigational Site, Bordeaux cedex, , France
GSK Investigational Site, Lille, , France
GSK Investigational Site, Lyon Cedex 08, , France
GSK Investigational Site, Marseille cedex 5, , France
GSK Investigational Site, Paris Cedex 5, , France
GSK Investigational Site, Saint-Priest en Jarez, , France
GSK Investigational Site, Vandoeuvre-Les-Nancy, , France
GSK Investigational Site, Villejuif, , France
GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany
GSK Investigational Site, Bad Saarow, Brandenburg, Germany
GSK Investigational Site, Frankfurt, Hessen, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Dresden, Sachsen, Germany
GSK Investigational Site, Napoli, Campania, Italy
GSK Investigational Site, Roma, Lazio, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Rozzano (MI), Lombardia, Italy
GSK Investigational Site, Candiolo (TO), Piemonte, Italy
GSK Investigational Site, Torino, Piemonte, Italy
GSK Investigational Site, Terni, Umbria, Italy
GSK Investigational Site, Aichi, , Japan
GSK Investigational Site, Chiba, , Japan
GSK Investigational Site, Fukuoka, , Japan
GSK Investigational Site, Hokkaido, , Japan
GSK Investigational Site, Mie, , Japan
GSK Investigational Site, Okayama, , Japan
GSK Investigational Site, Osaka, , Japan
GSK Investigational Site, Osaka, , Japan
GSK Investigational Site, Tokyo, , Japan
GSK Investigational Site, Daegu, , Korea, Republic of
GSK Investigational Site, Goyang-si, Gyeonggi-do, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Groningen, , Netherlands
GSK Investigational Site, Leiden, , Netherlands
GSK Investigational Site, Nijmegen, , Netherlands
GSK Investigational Site, Rotterdam, , Netherlands
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Palma de Mallorca, , Spain
GSK Investigational Site, Valencia, , Spain
GSK Investigational Site, Göteborg, , Sweden
GSK Investigational Site, Linköping, , Sweden
GSK Investigational Site, Lund, , Sweden
GSK Investigational Site, Umeå, , Sweden
GSK Investigational Site, Uppsala, , Sweden
GSK Investigational Site, Manchester, Lancashire, United Kingdom
GSK Investigational Site, Glasgow, , United Kingdom
GSK Investigational Site, Leeds, , United Kingdom
GSK Investigational Site, London, , United Kingdom
GSK Investigational Site, Nottingham, , United Kingdom
GSK Investigational Site, Sheffield, , United Kingdom
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
